已收盤 04-02 16:00:00 美东时间
+0.055
+0.11%
Feb 7 (Reuters) - Abbvie Inc ABBV.N: U.S. FDA APPROVES EMBLAVEO™ (AZTREONAM AND AVIBACTAM) FOR THE TREATMENT OF ADULTS WITH COMPLICATED INTRA-ABDOMINAL INFECTIONS WITH LIMITED OR NO TREATMENT OPTIONS ...
2025-02-08 04:12